MIMPARA Trademark

Trademark Overview

On Thursday, October 5, 2006, a trademark application was filed for MIMPARA with the United States Patent and Trademark Office. The USPTO has given the MIMPARA trademark a serial number of 77014804. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 13, 2010. This trademark is owned by Amgen Inc.. The MIMPARA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceuticals for modulating calcium, phosphorus, or parathyroid hormone levels in the blood or for treatment of hyperparathyroidism, hypercalcemia or bone metabolism related disorders and diseases
mimpara

General Information

Serial Number77014804
Word MarkMIMPARA
Filing DateThursday, October 5, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 13, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceuticals for modulating calcium, phosphorus, or parathyroid hormone levels in the blood or for treatment of hyperparathyroidism, hypercalcemia or bone metabolism related disorders and diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 10, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Monday, December 13, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 13, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 18, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 17, 2010EXTENSION 5 GRANTED
Monday, April 26, 2010EXTENSION 5 FILED
Wednesday, May 12, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 26, 2010TEAS EXTENSION RECEIVED
Friday, November 6, 2009EXTENSION 4 GRANTED
Wednesday, November 4, 2009EXTENSION 4 FILED
Wednesday, November 4, 2009TEAS EXTENSION RECEIVED
Thursday, April 9, 2009EXTENSION 3 GRANTED
Wednesday, April 8, 2009EXTENSION 3 FILED
Wednesday, April 8, 2009TEAS EXTENSION RECEIVED
Tuesday, September 30, 2008EXTENSION 2 GRANTED
Monday, September 29, 2008EXTENSION 2 FILED
Tuesday, September 30, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 29, 2008TEAS EXTENSION RECEIVED
Wednesday, May 14, 2008EXTENSION 1 GRANTED
Tuesday, April 29, 2008EXTENSION 1 FILED
Tuesday, April 29, 2008TEAS EXTENSION RECEIVED
Tuesday, November 13, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 21, 2007PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2007NOTICE OF PUBLICATION
Tuesday, May 15, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 15, 2007ASSIGNED TO LIE
Friday, April 27, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 27, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 27, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 27, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 6, 2006NON-FINAL ACTION E-MAILED
Monday, November 6, 2006NON-FINAL ACTION WRITTEN
Friday, November 3, 2006ASSIGNED TO EXAMINER
Tuesday, October 10, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

mimpara hypercalcemia hyperparathyroidism treatment bone metabolism diseases disorders related blood levels